
PMC:7376974 / 93336-94056
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T444 | 87-90 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1666 | 77-81 | Species | denotes | H1N1 | Tax:114727 |
1667 | 116-126 | Species | denotes | SARS-Cov-2 | Tax:2697049 |
1668 | 198-204 | Species | denotes | humans | Tax:9606 |
1669 | 458-468 | Species | denotes | SARS-Cov-2 | Tax:2697049 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T261 | 77-85 | Disease | denotes | H1N1 flu | http://purl.obolibrary.org/obo/MONDO_0005460 |
T262 | 82-85 | Disease | denotes | flu | http://purl.obolibrary.org/obo/MONDO_0005812 |
T263 | 96-100 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T264 | 116-120 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T265 | 458-462 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T859 | 19-22 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T860 | 152-155 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T861 | 198-204 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T862 | 307-310 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T863 | 456-457 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T864 | 655-656 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T865 | 700-709 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | extremely |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T865 | 668-684 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T568 | 0-101 | Sentence | denotes | The recent history has shown the spread of different viral pandemics such as H1N1 flu, HIV, and SARS. |
T569 | 102-264 | Sentence | denotes | Nowadays, the SARS-Cov-2 pandemic global lockdown has profoundly changed the daily life of most humans, causing uncertainty in short and middle time perspectives. |
T570 | 265-430 | Sentence | denotes | In this context, the scientific community has responded to protect the population by studying new vaccines and disinfection methods to be applied in the near future. |
T571 | 431-595 | Sentence | denotes | Despite this tough work, a SARS-Cov-2 vaccination will hopefully be available in 1–2 years, making this epidemic transient period gloomy with increased instability. |
T572 | 596-720 | Sentence | denotes | The study of more effective vaccines and the production of a wide range antiviral agents is nowadays an extremely hot topic. |